CTI BioPharma Announces Progress Of Lead Programs And Strategic Objectives For 2017. Pacritinib Drug developed by S*BIO, EDBI Portfolio Company

SEATTLE, Jan. 9, 2017 /PRNewswire/ — CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced positive progress on its lead programs in addition to key business priorities for 2017.

CTI BioPharma Announces Progress Of Lead Programs And Strategic Objectives For 2017. Pacritinib Drug developed by S*BIO, EDBI Portfolio Company Read More »

LogRhythm Announces New Global Resale Partnership

SAN JOSE, Calif., Oct. 25, 2016 /PRNewswire/ — RetailNext Inc., the worldwide
expert and market leader in retail IoT smart store analytics for optimizing shopper
experiences at brick-and-mortar retail stores, today announced its inclusion as one
of the “Best Entrepreneurial Companies in America” by Entrepreneur Magazine’s
Entrepreneur 360™ List, the most comprehensive analysis of private companies in
America.

LogRhythm Announces New Global Resale Partnership Read More »